| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,354,000 | 1,599,000 | 1,811,000 | 1,709,000 | | Cost of Revenue | 1,194,000 | 1,384,000 | 1,490,000 | 1,406,000 | | | Gross Profit | 160,000 | 215,000 | 321,000 | 303,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 207,000 | 194,000 | 212,000 | 202,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (47,000) | 21,000 | 109,000 | 101,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | 12,000 | (6,000) | 21,000 | | Earnings Before Interest And Taxes | (39,000) | 33,000 | 103,000 | 122,000 | | Interest Expense | 52,000 | 55,000 | 52,000 | 49,000 | | Income Before Tax | (91,000) | (22,000) | 51,000 | 73,000 | | Income Tax Expense | (12,000) | (6,000) | 5,000 | 15,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (79,000) | (16,000) | 46,000 | 58,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 8,000 | (2,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (79,000) | (16,000) | 54,000 | 56,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($79,000) | ($16,000) | $54,000 | $56,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
